PDX1 and neoplasm: These findings appear in contrast to our patient, who harbored a tumor with the immunohistochemical profile of a β-cell lineage and without any signs of α-cell differentiation (PDX1+/ARX−), although the exact consequences of SLGT1 knockout on α-β cell communication need to be fully clarified.